Analyst Ratings
Upgrades, downgrades, and price-target changes from Wall Street firms.
LifeSci Capital Reiterates Buy Rating on IMMX
LifeSci Capital maintains its buy rating on IMMX, setting a target price of $19.
Maxim Group Reiterates Buy Rating on OXBR
Analyst Allen Klee maintains a buy rating with a $3.00 target for OXBR.
Citigroup Reiterates Buy Rating for Micron Technology
Citigroup maintains its buy rating on Micron Technology with a target price of $1,200.
Citigroup Reiterates Buy Rating for Applied Materials, Inc.
Citigroup maintains its buy stance on Applied Materials, Inc., setting a $710 price target.
Citigroup Reaffirms Buy Rating for Lam Research, Sets $450 Target
Citigroup reiterated its buy rating for Lam Research with a $450 price target.
Stifel Reiterates Buy Rating for Valmont Industries
Stifel maintains its buy rating on Valmont Industries with a $645 price target.
Mizuho Upgrades HUN to Hold, Sets $14 Price Target
Mizuho analyst John Roberts upgraded HUN to a hold and set a $14 price target.
Mizuho Raises Western Midstream Partners to 'Buy' with $48 Target
Mizuho analyst Gabriel Moreen raises Western Midstream Partners to a 'buy', setting a $48 price target.
Northland Capital Reiterates Buy Rating on Applied Digital
Northland Capital maintains a buy rating on Applied Digital with an $82 target.
Raymond James Reiterates Buy Rating on Nexxen International Ltd.
Raymond James maintains a Buy rating on Nexxen with an $11 price target.
Roth Capital Reiterates Buy Rating on NNE
Roth Capital maintains its buy rating on NNE with a $45 price target.
B. Riley Securities Reiterates Buy Rating on SVC
B. Riley Securities maintains its buy rating on SVC with a $2.5 target price.
Deutsche Bank Reiterates Buy Rating on Micron Technology
Deutsche Bank maintains its optimistic outlook on Micron with a $1,500 price target.
Barrington Research Reiterates Buy Rating on Huron Consulting Group
Barrington Research maintains its buy rating on Huron Consulting Group, setting a $207 price target.
DA Davidson Reiterates Buy Rating on LPRO
DA Davidson maintains its buy rating on LPRO, setting a target price of $3.
RBC Capital Reiterates Buy Rating on Edgewise Therapeutics
RBC Capital maintains its buy rating on Edgewise Therapeutics with a $59 price target.
Wells Fargo Reiterates Buy Rating on Cummins Inc.
Wells Fargo reaffirms its buy rating for Cummins Inc., targeting $874.
Wells Fargo Maintains Buy Rating on FedEx Corporation
Wells Fargo reaffirms a buy rating on FedEx with a $425 price target.
Scotiabank Reiterates Buy Rating on Gildan Activewear
Scotiabank maintains its buy rating for Gildan Activewear with a $65 target.
Scotiabank Reiterates Buy Rating on Nexxen International
Scotiabank maintains its buy rating on Nexxen International with a target of $11.
Citigroup Maintains Buy Rating on Datadog with $270 Price Target
Citigroup reiterates its buy rating on Datadog, setting a $270 price target.
Argus Research Reiterates Buy Rating on Robinhood Markets, Inc.
Argus Research has reaffirmed its Buy rating on Robinhood Markets, Inc. with a price target of $110.
Piper Sandler Reiterates Buy Rating on Kimberly-Clark
Piper Sandler maintains a buy rating on Kimberly-Clark with a $121 price target.
TD Cowen Reiterates Buy Rating on Humacyte, Inc.
TD Cowen maintains its buy rating on Humacyte with a $1.25 target.
